drugset / Trial / NCT00489528

Growth Hormone in the Treatment of HIV-Associated Wasting

NCT00489528

Phase 3 Completed EMD Serono
RandomizedParallel-groupDouble-blindPrevention

Summary

The purpose of this study is to compare physical function and lean body mass in patients getting different doses of somatropin compared to patients not getting the drug.

Timeline

Start
1997-07
Primary completion
Completion
2002-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Somatropin Protein / enzyme biologic

Indications